I'm actually not certain the drugs are currently being used by ME/CFS patients. I don't recall that from any of the communications around the study.
In terms of footing the bill, the Association funded the study that identified these targets. I don't know who is footing the bill for the first trial - maybe Biovista and Association combined?
In terms of footing the bill, the Association funded the study that identified these targets. I don't know who is footing the bill for the first trial - maybe Biovista and Association combined?